Scientists in Brisbane and Ireland have developed a small molecule that blocks a key driver of inflammatory diseases – a finding that could inspire new treatments for arthritis, multiple sclerosis and a family of rare autoinflammatory diseases.
Researchers from The University of Queensland’s Institute for Molecular Bioscience have uncovered a secret of an immune cell on the frontline that could assist with developing new treatments for inflammatory diseases.
UQ’s Institute for Molecular Bioscience Lab Head Dr Kate Schroder has been awarded the Milstein Young Investigator award for her outstanding contributions to basic immunology research at the annual International Cytokine and Interferon Society meeting held in Melbourne this week.
Research to investigate new treatments for cancer, diabetes and inflammation are just some of the innovative projects at UQ’s Institute for Molecular Bioscience (IMB) to receive new funding from the National Health and Medical Research Council (NHMRC).
IMB researchers studying how the body fights infection and how venoms can ease pain have been named among Queensland’s best and brightest young scientists at the 2013 Tall Poppy Awards.
